Download PDF
CC BY 4.0 · Brazilian Journal of Oncology 2024; 20: s00441790567
DOI: 10.1055/s-0044-1790567
Original Article
Surgical Oncology

Clinicopathological Analysis and Survival of Patients with Cervical Cancer Submitted to Pelvic Exenteration

Bruno Marinho Pinto Águila 
1   Gynecologic Oncology Service, Instituto do Câncer do Ceará, Fortaleza, Ceará, Brazil.
,
Felipe de Lima Monteiro 
1   Gynecologic Oncology Service, Instituto do Câncer do Ceará, Fortaleza, Ceará, Brazil.
,
Héladio Feitosa de Castro Neto 
1   Gynecologic Oncology Service, Instituto do Câncer do Ceará, Fortaleza, Ceará, Brazil.
,
Bruno de Sousa Soares 
1   Gynecologic Oncology Service, Instituto do Câncer do Ceará, Fortaleza, Ceará, Brazil.
,
Jefferson Silva Oliveira 
1   Gynecologic Oncology Service, Instituto do Câncer do Ceará, Fortaleza, Ceará, Brazil.
,
Rodrigo de Oliveira Lima 
1   Gynecologic Oncology Service, Instituto do Câncer do Ceará, Fortaleza, Ceará, Brazil.
› Author Affiliations Funding The authors declare that they did not receive funding from agencies in the public, private or non-profit sectors to conduct the present study.

Clinical Trials? No
› Further Information
   Permissions and Reprints All articles of this category

Abstract

Justification The importance of this study arises from the high incidence and mortality of cervical cancer (CC), and the need to evaluate the effectiveness of current treatments, such as pelvic exenteration, performed in cases of persistent or recurrent carcinoma.

Objective To analyze the relationship between clinical and pathological factors and the results of mortality and recurrence in patients with CC who underwent pelvic exenteration at the Hospital Haroldo Juaçaba, from 2000 to 2019, aiming to improve the understanding of this procedure's outcomes.

Materials and Methods Observational, cross-sectional, retrospective study, using medical record consultation.

Results Patients with perineural invasion, those with prior surgical treatment, and those who underwent radical surgery had lower disease-free survival rates. Also, patients over 50-years-old had lower overall survival than those under that age range.

Conclusion Pelvic exenteration is a high-risk treatment for malignant pelvic neoplasms, with results influenced by technique and institutional resources. Despite the risks, it can control the disease in the long term and even cure it. However, it can affect quality of life and sexual function. Young patients should be made aware of CC prevention methods.

Keywords

cervical cancer - pelvic exenteration - survival

Author's Contribution

BMPA: data collection, assembly, analysis, and interpretation, study conception and design, writing and final approval of the manuscript, provision of study materials or patients. FLM: data analysis and interpretation, final approval of the manuscript. HFCN: writing and final approval of the manuscript, provision of study materials or patient. BSS: collection and assembly of data, final approval of the manuscript. JSO: collection and assembly of data, study conception and design.




Publication History

Received: 05 May 2024

Accepted: 18 July 2024

Article published online:
28 September 2024

© 2024. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution 4.0 International License, permitting copying and reproduction so long as the original work is given appropriate credit (https://creativecommons.org/licenses/by/4.0/)

Thieme Revinter Publicações Ltda.
Rua do Matoso 170, Rio de Janeiro, RJ, CEP 20270-135, Brazil

Bibliographical Record
Bruno Marinho Pinto Águila, Felipe de Lima Monteiro, Héladio Feitosa de Castro Neto, Bruno de Sousa Soares, Jefferson Silva Oliveira, Rodrigo de Oliveira Lima. Clinicopathological Analysis and Survival of Patients with Cervical Cancer Submitted to Pelvic Exenteration. Brazilian Journal of Oncology 2024; 20: s00441790567.
DOI: 10.1055/s-0044-1790567
 

  • References

  • 1 Instituto Nacional do Câncer - INCA (Brasil). Dados e números sobre Câncer de Colo do Útero - Relatório Anual 2022 [Internet]. [citado 16 fev 2023]. Disponível em: https://antigo.inca.gov.br/sites/ufu.sti.inca.local/files//media/document//dados_e_numeros_colo_22marco2023.pdf
    Google Scholar
  • 2 Instituto Nacional do Câncer - INCA (Brasil). Informativo Detecção Precoce - Monitoramento das ações de controle do câncer de colo do útero [Internet]. [citado 16 fev 2023]. Disponível em: https://www.inca.gov.br/sites/ufu.sti.inca.local/files//media/document//informativo21.pdf
    Google Scholar
  • 3 International Agency for Research on Cancer (IARC). Cancer today. Lyon: WHO; 2020. [citado 2 mar 2023]. Disponível em: https://gco.iarc.fr/today/home
    Google Scholar
  • 4 Instituto Nacional do Câncer - INCA (Brasil). Mortalidade por Câncer de Colo de Útero [Internet]. [citado 16 fev 2023]. Disponível em: https://www.gov.br/inca/pt-br/assuntos/gestor-e-profissional-de-saude/controle-do-cancer-do-colo-do-utero/dados-e-numeros/mortalidade
    Google Scholar
  • 5 Oliveira Júnior A. Mortalidade por neoplasia maligna do colo do útero no estado do Ceará de 2014 a 2019: perfil epidemiológico. . Res Soc Dev 2022;11(05):
    Google Scholar
  • 6 Holanda JCR, Araújo MHHPO, Nascimento WG, Gama MPA, Sousa CSM. Uso do protocolo de saúde da mulher na prevenção do câncer de colo do útero. Rev Baiana Enferm 2021; •••: 35
    Google Scholar
  • 7 Laporte GA, Zanini LAG, Zanvettor PH. et al. Guidelines of the Brazilian Society of Oncologic Surgery for pelvic exenteration in the treatment of cervical cancer. J Surg Oncol 2020; 121 (05) 718-729
    Google Scholar
  • 8 Correia RA. et al. Qualidade de vida após o tratamento de câncer de colo do útero. . Esc Anna Nery 2018;22(04):
    Google Scholar
  • 9 Filho RCS. et al. Indicações e complicações da exenteração pélvica no câncer ginecológico. Feminina. 2014; 42 (02) 77-82
    Google Scholar
  • 10 Petruzziello A, Kondo W, Hatschback SB. et al. Surgical results of pelvic exenteration in the treatment of gynecologic cancer. World J Surg Oncol 2014; 12: 279
    Google Scholar
  • 11 Brunschwig A. Complete excision of pelvic viscera for advanced carcinoma; a one-stage abdominoperineal operation with end colostomy and bilateral ureteral implantation into the colon above the colostomy. Cancer 1948; 1 (02) 177-183
    Google Scholar
  • 12 Höckel M, Dornhöfer N. Pelvic exenteration for gynaecological tumours: achievements and unanswered questions. Lancet Oncol 2006; 7 (10) 837-847
    Google Scholar
  • 13 Vieira SC, Costa DR, Meneses AD, Borges e Silva J, Oliveira AKS, Sousa RB. Exenteração pélvica para câncer do colo uterino recidivado pós-radioterapia: experiência de um centro terciário do Nordeste brasileiro. Rev Bras Ginecol Obstet 2009; 31 (01) 22-27
    Google Scholar
  • 14 Lewandowska A, Szubert S, Koper K, Koper A, Cwynar G, Wicherek L. Analysis of long-term outcomes in 44 patients following pelvic exenteration due to cervical cancer. World J Surg Oncol 2020; 18 (01) 234
    Google Scholar
  • 15 Matsuo K, Mandelbaum RS, Adams CL, Roman LD, Wright JD. Performance and outcome of pelvic exenteration for gynecologic malignancies: A population-based study. Gynecol Oncol 2019; 153 (02) 368-375
    Google Scholar
  • 16 de Gregorio N, de Gregorio A, Ebner F. et al. Pelvic exenteration as ultimate ratio for gynecologic cancers: single-center analyses of 37 cases. Arch Gynecol Obstet 2019; 300 (01) 161-168
    Google Scholar
  • 17 Li L, Ma SQ, Tan XJ, Zhong S, Wu M. Pelvic Exenteration for Recurrent and Persistent Cervical Cancer. Chin Med J (Engl) 2018; 131 (13) 1541-1548
    Google Scholar
  • 18 Benn T, Brooks RA, Zhang Q. et al. Pelvic exenteration in gynecologic oncology: a single institution study over 20 years. Gynecol Oncol 2011; 122 (01) 14-18
    Google Scholar
  • 19 Tortorella L, Casarin J, Mara KC. et al. Prediction of short-term surgical complications in women undergoing pelvic exenteration for gynecological malignancies. Gynecol Oncol 2019; 152 (01) 151-156
    Google Scholar
  • 20 Barros AV. Papel do resgate cirúrgico no tratamento do câncer do colo uterino localmente avançado [dissertação]. São Paulo: Fundação Antônio Prudente; 2020. Available at: https://docs.bvsalud.org/biblioref/2021/12/1349017/aldo-vieira-barros.pdf
  • 21 Valério MP. et al. Câncer de colo de útero: do diagnóstico ao tratamento. Brazilian J Dev. 2022; 8 (03) 20235-20241
    Google Scholar
  • 22 NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) Version I. 2018 . National Comprehensive Cancer Network; 2017 [citado 17 mar 2023]. Disponível em: http://www.nccn.org/
    Google Scholar
  • 23 Yang K, Cai L, Yao L. et al. Laparoscopic total pelvic exenteration for pelvic malignancies: the technique and short-time outcome of 11 cases. World J Surg Oncol 2015; 13: 301
    Google Scholar
  • 24 Castro LM, Vieira SC. Sobrevida após exenteração pélvica em câncer de colo do útero recidivado: uma série de cinco casos. Femina 2021; 49 (07) 444-448
    Google Scholar
  • 25 Cibula D, Zikan M, Fischerova D. et al. Pelvic floor reconstruction by modified rectus abdominis myoperitoneal (MRAM) flap after pelvic exenterations. Gynecol Oncol 2017; 144 (03) 558-563
    Google Scholar
  • 26 Lin AJ, Ma S, Markovina S. et al. Clinical outcomes after isolated pelvic failure in cervical cancer patients treated with definitive radiation. Gynecol Oncol 2019; 153 (03) 530-534
    Google Scholar
  • 27 Karmaniolou I, Arkadopoulos N, Vassiliou P. et al. Pelvic Exenteration Put into Therapeutical and Palliative Perspective: It Is Worth to Try. Indian J Surg Oncol 2018; 9 (04) 552-557
    Google Scholar
  • 28 Chiantera V, Rossi M, De Iaco P. et al. Survival after curative pelvic exenteration for primary or recurrent cervical cancer: a retrospective multicentric study of 167 patients. Int J Gynecol Cancer 2014; 24 (05) 916-922
    Google Scholar
  • 29 Backes FJ, Tierney BJ, Eisenhauer EL, Bahnson RR, Cohn DE, Fowler JM. Complications after double-barreled wet colostomy compared to separate urinary and fecal diversion during pelvic exenteration: time to change back?. Gynecol Oncol 2013; 128 (01) 60-64
    Google Scholar
  • 30 Rutledge FN, McGuffee VB. Pelvic exenteration: prognostic significance of regional lymph node metastasis. Gynecol Oncol 1987; 26 (03) 374-380
    Google Scholar